Drugs / CBG131
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07394205 | Sep 2026 → Mar 2027 expected | digestive system neoplasm | First Affiliated Hospital of Wenzhou Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBG131 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07394205 ↗ |
| Modality | Cell therapy | “Get a single infusion of CBG131 CAR-T cells through an IV.” NCT07394205 ↗ |
| Route | Intravenous | “through an IV” NCT07394205 ↗ |